---
title: "The concept of innovative drugs fluctuates and rebounds, ClinPlus rises over 10%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247733884.md"
description: "The innovative drug concept fluctuated and rebounded during the day, with the CXO sector leading the gains. ClinPlus rose over 10%, while Medicilon, JZT, Thalys, HUIYU PHARMACEUTICAL, and Shanghai Yizhong all rose over 6%"
datetime: "2025-07-09T02:12:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247733884.md)
  - [en](https://longbridge.com/en/news/247733884.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247733884.md)
---

# The concept of innovative drugs fluctuates and rebounds, ClinPlus rises over 10%

The concept of innovative drugs fluctuated and rebounded during the day, with the CXO sector leading the gains. ClinPlus rose over 10%, while Medicilon, JZT, Thalys, HUIYU PHARMACEUTICAL, and Shanghai Yizhong all rose over 6%

### Related Stocks

- [301257.CN](https://longbridge.com/en/quote/301257.CN.md)
- [688202.CN](https://longbridge.com/en/quote/688202.CN.md)
- [000989.CN](https://longbridge.com/en/quote/000989.CN.md)
- [603716.CN](https://longbridge.com/en/quote/603716.CN.md)
- [688553.CN](https://longbridge.com/en/quote/688553.CN.md)

## Related News & Research

- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [Premium skincare brand Forest Cabin will study L’Oreal, but not copy it: CEO interview](https://longbridge.com/en/news/286831488.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [US Senator Durbin urges RFK. Jr to resist easing vape rules](https://longbridge.com/en/news/287079463.md)